학술논문

Effect of volume- and time-based constraints on capture of analytes in microfluidic heterogeneous immunoassaysPart of a special issue on Point-of-care Microfluidic Diagnostics; Guest Editors—Professor Kricka and Professor Sia.Electronic supplementary information (ESI) available: further discussion of theoretical model; variation of Csover capture zone; effect of varying L0on captured analytes; movie of flow and capture of analytes; reproducibility of passive adsorption of mouse IgG antibody onto polystyrene; experimental microfluidic immunoassay: further effect of finite-time constraint. See DOI: 10.1039/b813350f
Document Type
Article
Source
Lab on a Chip. Dec2008, Vol. 8 Issue 12, p2062-2070. 9p.
Subject
*MICROFLUIDICS
*IMMUNOASSAY
*HETEROGENEOUS computing
*RADIOLIGAND assay
*MASS transfer
*POINT-of-care testing
Language
ISSN
1473-0197
Abstract
Despite the prevalence of microfluidic-based heterogeneous immunoassays (where analytes in solution are captured on a solid surface functionalized with a capture molecule), there is incomplete understanding of how assay parameters influence the amount of captured analytes. This study presents computational results and corresponding experimental binding assays in which the capture of analytes is studied under variations in both mass transfer and surface binding, constrained by real-world assay conditions of finite sample volume, assay time, and capture area. Our results identify: 1) a “reagent-limited” regime which exists only under the constraints of finite sample volume and assay time; 2) a critical flow rate (e.g.0.5 µL min−1under our assay conditions) to gain the maximum signal with the fastest assay time; 3) an increase in signal by using a short concentrated plug (e.g.5 µL, 100 nM) rather than a long dilute plug (e.g.50 µL, 10 nM) of sample; 4) the possibility of spending a considerable fraction of the assay time out of the reaction-limited regime. Overall, an improved understanding of fundamental physical processes may be particularly beneficial for the design of point-of-care assays, where volumes of reagents and available samples are limited, and the desired time-to-result short. [ABSTRACT FROM AUTHOR]